Abstract
From a recent report on chemotherapy of urological tumours some conclusions can be drawn. The best indications for cancer chemotherapy in urology can be found in the treatment of metastatic testicular carcinoma, in the combined treatment of Wilms’ tumour and in the topical instillations of thiotepa in diffuse papillomatosis. The value of chemotherapeutic agents in prevention of recurrences of papillary bladder tumours is also emphasized. The association of 5-FU infusions to cobalt-teletherapy is strongly advocated. The results are, however, much less encouraging in other neoplasms, where only a limited number of transient regressions and subjective improvements can be observed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
